The bottom line: We maintain our $200 fair value estimate for wide-moat Apple. We believe our long-term thesis for slowing ...

Jobless claims and the first estimate of fourth-quarter productivity are due at 8:30 a.m. Eastern. The key nonfarm payrolls report is due on Friday.

BYD's sharp share gains today are likely due to the upcoming press conference, Bocom International analyst Angus Chan said, adding that analysts are expecting there will be an increase in number of ...

In Europe, the Stoxx Europe 600 gained 0.5% in morning trading. A.P. Moeller-Maersk B added 7.2% and Societe Generale rose 6.9%. On the other hand, Lotus Bakeries dropped 4.4%, and GN Store Nord ...

The Danish renewable-energy company expects earnings before interest, taxes, depreciation and amortization excluding new partnerships and cancellation fees at between 25 billion and 28 billion kroner ...

The result compares with analysts' expectations of $1.31 billion in net profit on $13.89 billion in revenue, according to a Visible Alpha consensus. Maersk's ocean segment, its container shipping ...

In a speech to business leaders, Naoki Tamura said that the central bank should raise rates to 1% or higher in the fiscal half starting in October. Investors are pricing in a 97% chance that the U.K.

Kering's flagship label Gucci said it ended its collaboration with creative director Sabato De Sarno, at a time when the brand is facing weak demand and as the French group seeks to rejuvenate its ...

AstraZeneca anticipates further sales and earnings growth this year after its fourth-quarter results topped analysts' expectations, boosted by high demand for its key drugs that offset a slight sales ...

Compass Group reported a rise in revenue for the first quarter, reflecting growth across all divisions and continued strong client retention. The London-listed catering contractor said Thursday that ...

A.P. Moeller-Maersk swung to a net profit in the fourth quarter that exceeded analysts' expectations, as disruptions to the Red Sea shipping supported higher shipping rates.

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China. The company disclosed preliminary results in mid January, but it left out important ...